According to the Financial Times, 13.9% of patients being treated with Gilead Sciences' drug remdesivir died, versus 12.8% receiving standard care.
Initial jobless claims for last week were 4.
Track emerging trends and changes in the mining finance landscape along with investor...
A comprehensive annual review of mining risk, including a jurisdiction-by-jurisdiction...
Discover the most prominent challenges for mining company C-suite executives both...
Discover the methodology behind our development-asset database, along with a sample...
date:12/10/2020
location:Virtual Event
Providing investors with access to the very best mining projects from exploration to production.
date:02/11/2020
location:Virtual Event
Mining Journal Select 365: Mining. Investment. Online.
date:22/02/2021
location:Sofitel, Sydney, Australia
Exceptional investment opportunities selected by Mining Journal
Position Location: Sydney
We are seeking a motivated and experienced Production Manager in the Elastomer Division
Position Location: Sydney
We currently have a vacancy for an experienced and motivated Maintenance Manager
Position Location: Sydney
We currently have a vacancy for an experienced and motivated Electrical Supervisor
Position Location: Perth
Exciting executive management role. Join a company experiencing growth.
WALL Street finished almost unchanged, giving up earlier gains after a trial for a COVID-19 treatment appeared to fail.
According to the Financial Times, 13.9% of patients being treated with Gilead Sciences' drug remdesivir died, versus 12.8% receiving standard care.
Initial jobless claims for last week were 4.
Miners' annus horribilis continues with mine mothballed and guidance dropped
Capital Watch: TNG, Tao, and more
Buy, Sell, Hold: BHP, FMG and Genesis
Global Wrap: Glencore, Vale and more